Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Sales | 11,612 | 8,831 | 0 | 0 | 0 |
| Gross Profit | 11,612 | 8,831 | N/A | N/A | N/A |
| Operating Expenses | 15,729 | 9,584 | 0 | 0 | 0 |
| Operating Income | -4,117 | -753 | N/A | N/A | N/A |
| Interest Expense | 209 | 212 | 0 | 0 | 0 |
| Other Income | 2,115 | 1,274 | 0 | 0 | 0 |
| Pre-tax Income | -2,211 | 309 | 0 | 0 | 0 |
| Net Income Continuous | -2,211 | 309 | N/A | N/A | N/A |
| Net Income | $-2,211 | $309 | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -0.01 | 0.00 | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -0.01 | 0.00 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.01 | 0.00 | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | N/A | N/A | N/A |
| EBITDA(a) | $-2,270 | $-23 | $N/A | $N/A | $N/A |